Unia Europejska -
norweski -
EMA (European Medicines Agency)
competact
cheplapharm arzneimittel gmbh - pioglitazone, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.
Norwegia -
norweski -
Statens legemiddelverk
questran loc 4 g
cheplapharm arzneimittel gmbh - kolestyramin - pulver til mikstur, suspensjon - 4 g
Norwegia -
norweski -
Statens legemiddelverk
questran 4 g
cheplapharm arzneimittel gmbh - kolestyramin - pulver til mikstur, suspensjon - 4 g
Norwegia -
norweski -
Statens legemiddelverk
rivotril 0.5 mg
cheplapharm arzneimittel gmbh - klonazepam - tablett - 0.5 mg
Norwegia -
norweski -
Statens legemiddelverk
rivotril 2 mg
cheplapharm arzneimittel gmbh - klonazepam - tablett - 2 mg
Norwegia -
norweski -
Statens legemiddelverk
actos 30 mg
orifarm as - pioglitazonhydroklorid - tablett - 30 mg
Norwegia -
norweski -
Statens legemiddelverk
xenical 120 mg
orifarm as - orlistat - kapsel, hard - 120 mg
Norwegia -
norweski -
Statens legemiddelverk
calcigran forte 500 mg / 400 ie
orifarm healthcare a/s - kalsiumkarbonat / kolekalsiferol - tyggetablett - 500 mg / 400 ie
Norwegia -
norweski -
Statens legemiddelverk
calcigran forte sitron 500 mg / 800 ie
orifarm healthcare a/s - kalsiumkarbonat / kolekalsiferol - tyggetablett - 500 mg / 800 ie